PROJECT JupitR

OmnigeniQ combines next-generation biophysics and AI to identify the mechanistic reasons why ~90% of drug candidates fail in clinical trials.

By simulating real-time interactions between molecules and human targets, we aim to improve early-stage decision-making, reduce late-stage attrition, and accelerate the path to personalized, effective treatments.

FAQs

JupitR WILL be used for

Disease Modelling

Simulations can be done EARLY and are agnostic to drug and receptor type.

In Vivo Drug Simulation

Artificial Intelligence interprets the mathematical output into a biological context that clients can use instantly.

Ageing

An average simulation takes 8 minutes. Full analysis and reports are available to clients in less than 1 hour.

How does JupitR produce rapid, usable intelligence?

Molecule Intake

JupitR is able to work with any ligand .sdf file (2D or 3D) or even parse from SMILES / InCHIKey

Curated Receptor Field

JupitR uses curated receptor batches to simulate a continuous quantum field system

Data Enrichment

JupitR enriches all uploaded data via OmnigeniQ’s

proprietary quantum biophysics protocol

T: 1800 329 157 | E: info@omnigeniq.com

This website uses cookies.

We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.